The store will not work correctly when cookies are disabled.
N-((4-(4-(tert-butyl)phenyl)quinazolin-8-yl)methyl)acetimidamide
ID: ALA2413355
PubChem CID: 71657295
Max Phase: Preclinical
Molecular Formula: C21H24N4
Molecular Weight: 332.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=N)NCc1cccc2c(-c3ccc(C(C)(C)C)cc3)ncnc12
Standard InChI: InChI=1S/C21H24N4/c1-14(22)23-12-16-6-5-7-18-19(24-13-25-20(16)18)15-8-10-17(11-9-15)21(2,3)4/h5-11,13H,12H2,1-4H3,(H2,22,23)
Standard InChI Key: QCIYYUKNPNVICH-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.3360 -13.7123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3348 -14.5396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0497 -14.9525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0479 -13.2995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7632 -13.7087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7640 -14.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4793 -14.9465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1943 -14.5317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1895 -13.7017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4736 -13.2945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0516 -15.7775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3381 -16.1916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4693 -12.4696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1826 -12.0590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1786 -11.2348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4614 -10.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7469 -11.2459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7543 -12.0688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4560 -10.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1677 -9.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7388 -9.5925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4499 -9.1749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3400 -17.0166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6265 -17.4308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0554 -17.4274 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
11 12 1 0
10 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
12 23 1 0
23 24 1 0
23 25 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.45 | Molecular Weight (Monoisotopic): 332.2001 | AlogP: 4.68 | #Rotatable Bonds: 3 |
Polar Surface Area: 61.66 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 12.11 | CX LogP: 4.07 | CX LogD: 1.66 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.54 | Np Likeness Score: -0.72 |
References
1. Parhi AK, Zhang Y, Saionz KW, Pradhan P, Kaul M, Trivedi K, Pilch DS, LaVoie EJ.. (2013) Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines., 23 (17): [PMID:23891185] [10.1016/j.bmcl.2013.06.048] |